YOR231C-A Antibody

What is YOR231C-A and why is it significant in yeast research?

YOR231C-A refers to a specific protein in Saccharomyces cerevisiae (Baker's yeast) strain ATCC 204508/S288c. This protein is studied in fundamental yeast biology research to understand cellular processes. The antibody against YOR231C-A is significant because it allows researchers to detect, quantify, and localize this protein in experimental settings. The antibody serves as a critical reagent for investigating protein expression, function, and interaction networks in yeast, which is an important model organism in molecular biology. Understanding YOR231C-A contributes to our broader knowledge of eukaryotic cellular mechanisms that may have implications across species .

What are the key properties of the YOR231C-A antibody?

The YOR231C-A antibody is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) YOR231C-A protein. It has the following specifications:

• Type: Polyclonal antibody

• Host species: Rabbit

• Target species reactivity: Saccharomyces cerevisiae (strain ATCC 204508/S288c)

• Applications: ELISA and Western Blot (WB)

• Form: Liquid

• Purification method: Antigen affinity purified

• Isotype: IgG

• Storage buffer: Contains 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4

What are the validated applications for YOR231C-A antibody?

The YOR231C-A antibody has been validated for two primary applications:

• ELISA (Enzyme-Linked Immunosorbent Assay): This application allows for the quantitative detection of the YOR231C-A protein in samples. The antibody can be used as a primary antibody in indirect ELISA setups to measure relative abundance of the target protein.

• Western Blot (WB): This technique enables the detection of YOR231C-A protein in cell lysates or purified samples, providing information about protein size, expression levels, and potential post-translational modifications.

These validated applications ensure identification of the antigen with high specificity. While other applications such as immunohistochemistry, immunofluorescence, or immunoprecipitation might be possible, they would require additional validation by the researcher before reliable use in experimental protocols .

What is the recommended protocol for Western blot using YOR231C-A antibody?

Recommended Western Blot Protocol for YOR231C-A Antibody:

• Sample Preparation:

  • Prepare yeast cell lysates using standard methods (glass bead lysis or enzymatic digestion)

  • Add protease inhibitors to prevent protein degradation

  • Denature samples in loading buffer at 95°C for 5 minutes

• Gel Electrophoresis:

  • Load 20-50 μg of total protein per lane

  • Separate proteins on 10-12% SDS-PAGE gel

  • Include molecular weight markers

• Transfer:

  • Transfer proteins to PVDF or nitrocellulose membrane (PVDF recommended for better protein retention)

  • Transfer at 100V for 1 hour or 30V overnight at 4°C

• Blocking:

  • Block membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Primary Antibody Incubation:

  • Dilute YOR231C-A antibody 1:500 to 1:2000 in blocking solution

  • Incubate overnight at 4°C with gentle rocking

• Washing:

  • Wash membrane 3-5 times with TBST, 5 minutes each

• Secondary Antibody Incubation:

  • Use anti-rabbit IgG HRP-conjugated secondary antibody

  • Dilute 1:5000 in blocking solution

  • Incubate for 1 hour at room temperature

• Detection:

  • Wash membrane 3-5 times with TBST, 5 minutes each

  • Apply ECL substrate and detect signal using imaging system

This protocol may require optimization based on specific laboratory conditions and sample types .

What are common issues encountered when using YOR231C-A antibody and how can they be resolved?

When working with YOR231C-A antibody, researchers may encounter several challenges that can impact experimental outcomes. Here are common issues and their potential solutions:

Issue 1: Weak or No Signal in Western Blot

• Potential causes: Insufficient antibody concentration, degraded antibody, low target protein expression, inefficient transfer

• Solutions:

  • Increase antibody concentration (try 1:250 dilution)

  • Confirm antibody activity with positive control

  • Increase protein loading (75-100 μg)

  • Optimize transfer conditions for high molecular weight proteins

  • Extend exposure time during detection

  • Try more sensitive detection systems

Issue 2: High Background or Non-specific Binding

• Potential causes: Insufficient blocking, excessive antibody concentration, cross-reactivity

• Solutions:

  • Extend blocking time to 2 hours or overnight

  • Use alternative blocking agents (BSA instead of milk)

  • Increase washing duration and frequency

  • Reduce primary antibody concentration

  • Add 0.1-0.5% Tween-20 to antibody diluent

Issue 3: Multiple Bands in Western Blot

• Potential causes: Protein degradation, post-translational modifications, cross-reactivity

• Solutions:

  • Use fresh samples with added protease inhibitors

  • Optimize lysis conditions to prevent protein degradation

  • Run denaturing gels under reducing conditions

  • Perform peptide competition assay to confirm specificity

Methodical troubleshooting and careful optimization of protocols are essential for obtaining reliable and reproducible results with the YOR231C-A antibody.

How can epitope masking issues be addressed when working with YOR231C-A antibody?

Epitope masking occurs when the target binding site of an antibody is obscured by protein folding, post-translational modifications, or protein-protein interactions. For YOR231C-A antibody, consider these methodological approaches:

• Optimize Sample Preparation:

  • Test different lysis buffers with varying detergent types and concentrations

  • Evaluate different reduction and denaturation conditions

  • Try heat denaturation at different temperatures (70°C, 85°C, 95°C)

• Modify Antigen Retrieval Methods:

  • For fixed samples, test different antigen retrieval solutions (citrate buffer, EDTA buffer)

  • Optimize retrieval pH (pH 6.0, 8.0, 9.0) and duration

• Test Alternative Detection Methods:

  • If Western blot detection is challenging, try native PAGE

  • Consider using proximity ligation assays for in situ detection

  • Implement dot blots for preliminary testing

• Cross-linking Experiments:

  • Use reversible cross-linking agents before sample preparation

  • Try different fixation protocols to preserve epitope accessibility

These methodological adjustments can help overcome epitope masking issues and improve detection of the YOR231C-A protein in various experimental contexts.

How can YOR231C-A antibody be used in studies of protein-protein interactions?

The YOR231C-A antibody can be valuable for investigating protein-protein interactions through several advanced methodological approaches:

• Co-Immunoprecipitation (Co-IP):

  • Use YOR231C-A antibody to precipitate the target protein along with its binding partners

  • Protocol modification: Crosslink the antibody to protein A/G beads to prevent antibody contamination in the eluate

  • Gentle lysis conditions with non-ionic detergents (0.5-1% NP-40 or 0.5% Triton X-100) help preserve protein-protein interactions

  • Follow with mass spectrometry analysis to identify interaction partners

• Proximity Ligation Assay (PLA):

  • Combine YOR231C-A antibody with antibodies against suspected interaction partners

  • This method can detect proteins that are within 40nm of each other in fixed cells

  • Quantify interaction signals using fluorescence microscopy

• Bimolecular Fluorescence Complementation (BiFC):

  • This technique requires genetic modification but can be validated using the antibody

  • YOR231C-A antibody confirms expression of fusion proteins in BiFC experiments

• FRET Analysis Validation:

  • Use the antibody to confirm expression and localization of fusion proteins in FRET experiments

  • Immunofluorescence with YOR231C-A antibody can validate FRET results

For robust results, include appropriate controls such as IgG isotype controls for Co-IP and reverse Co-IP experiments to confirm specificity of interactions. These methodological approaches enable researchers to explore the role of YOR231C-A in yeast protein interaction networks and signaling pathways.

What considerations should be taken into account when using YOR231C-A antibody for quantitative studies?

When employing YOR231C-A antibody for quantitative studies, several methodological considerations are crucial for generating reliable and reproducible data:

• Standardization and Calibration:

  • Develop a standard curve using purified recombinant YOR231C-A protein

  • Include internal loading controls (e.g., actin, GAPDH) for normalization

  • Use analytical software to quantify band intensities in Western blots

• Signal-to-Noise Optimization:

  • Determine the linear range of detection for the antibody

  • Work within this range to ensure quantitative accuracy

  • Implement background subtraction in image analysis

• Statistical Validation:

  • Perform at least three biological replicates

  • Apply appropriate statistical tests based on data distribution

  • Calculate coefficient of variation between replicates (<15% is generally acceptable)

• Technical Considerations:

  • Maintain consistent sample preparation, antibody concentration, and incubation times

  • Use automated systems when possible to reduce human error

  • Document all experimental conditions meticulously for reproducibility

• Comparative Analysis Methods:

  • For relative quantification in Western blots:

    • Densitometry with normalization to housekeeping proteins

    • Calculate relative expression as percentage of control samples

  • For absolute quantification in ELISA:

    • Use purified YOR231C-A protein to generate standard curves

    • Interpolate unknown sample concentrations from the standard curve

These methodological considerations ensure that quantitative studies using YOR231C-A antibody yield meaningful and statistically sound results that can be reliably interpreted in the context of yeast biology research.

How should negative and positive controls be designed for experiments using YOR231C-A antibody?

Proper control design is essential for interpreting results obtained with YOR231C-A antibody. Implement these methodological approaches for robust experimental controls:

Positive Controls:

• Recombinant YOR231C-A Protein:

  • Use purified recombinant protein as a definitive positive control

  • This confirms antibody functionality and provides size reference

• Overexpression Systems:

  • Samples from yeast strains overexpressing YOR231C-A

  • Particularly useful when endogenous expression is low

• Wild-type Yeast Samples:

  • Samples from S. cerevisiae strain ATCC 204508/S288c with known expression

  • Provides baseline for normal expression levels

Negative Controls:

• YOR231C-A Knockout/Deletion Mutants:

  • Yeast strains with the YOR231C-A gene deleted

  • Confirms antibody specificity and identifies non-specific signals

• Pre-immune Serum Controls:

  • When available, use serum from the same rabbit before immunization

  • Controls for natural antibodies that might cross-react

• Antibody Controls:

  • Include isotype-matched irrelevant antibody control

  • Peptide competition assay where antibody is pre-incubated with excess antigen

• Species Controls:

  • Test on non-target yeast species or distant strains

  • Helps evaluate potential cross-reactivity

What methodological approaches can improve reproducibility when working with YOR231C-A antibody?

Ensuring reproducibility is critical in antibody-based research. For YOR231C-A antibody experiments, implement these methodological strategies:

• Antibody Validation and Characterization:

  • Document antibody lot number and supplier information

  • Perform initial validation tests for each new lot

  • Create working aliquots to minimize freeze-thaw cycles

• Standardized Protocols:

  • Develop detailed, step-by-step protocols with precise measurements

  • Include specific incubation times, temperatures, and buffer compositions

  • Document any protocol modifications and their effects

• Sample Preparation Consistency:

  • Standardize cell growth conditions (media, temperature, growth phase)

  • Use consistent cell lysis methods and buffer compositions

  • Process all experimental samples simultaneously when possible

• Quantification and Analysis:

  • Establish clear rules for image acquisition and analysis

  • Use consistent exposure settings for all comparative experiments

  • Apply identical data processing steps across all samples

• Documentation and Reporting:

  • Maintain comprehensive laboratory records

  • Document all experimental conditions, including equipment settings

  • Report detailed methods in publications, following ARRIVE guidelines

• Reagent Quality Control:

  • Test critical reagents before large experiments

  • Use freshly prepared buffers and solutions

  • Record expiration dates and storage conditions

• Technical Replication Strategy:

  • Perform experiments in technical triplicates

  • Conduct biological replicates on separate days

  • Calculate and report variability metrics (standard deviation, CV%)

Implementing these methodological approaches creates a systematic framework for generating reliable and reproducible results with YOR231C-A antibody across different researchers and laboratory settings.

How should results from YOR231C-A antibody experiments be analyzed in the context of yeast biology?

Interpreting data from YOR231C-A antibody experiments requires consideration of both technical aspects and biological context:

• Expression Pattern Analysis:

  • Compare expression levels across different growth phases

  • Analyze changes under various stress conditions

  • Correlate expression with other proteins in related pathways

• Localization Interpretation:

  • Compare with known localization patterns of similar yeast proteins

  • Correlate subcellular distribution with protein function

  • Consider dynamic changes in localization during cell cycle

• Functional Correlation:

  • Link expression data with phenotypic observations

  • Correlate with transcriptomic and proteomic datasets

  • Interpret results in the context of known yeast biological processes

• Comparative Analysis Framework:

  • Compare results with published literature on YOR231C-A

  • Consider evolutionary conservation across fungal species

  • Integrate findings with broader yeast interactome studies

• Statistical Analysis Approaches:

  • Apply appropriate statistical tests based on experimental design

  • Use multiple comparison corrections for large datasets

  • Consider biological significance beyond statistical significance

These analytical approaches help place YOR231C-A antibody results within the broader context of yeast biology and contribute to understanding the protein's role in cellular processes.

What approaches can help distinguish genuine results from artifacts when using YOR231C-A antibody?

Distinguishing real signals from artifacts is critical for accurate interpretation of YOR231C-A antibody experiments. Implement these methodological verification strategies:

• Cross-Validation With Multiple Methods:

  • Confirm key findings using orthogonal techniques

  • Compare antibody results with GFP-tagging or other detection methods

  • Validate protein levels with RT-qPCR for transcript levels

• Artifact Identification Techniques:

  • Run technical controls to identify common artifacts:

    • Measure background signal in knockout strains

    • Test for non-specific binding with competing antigens

    • Evaluate signal in non-target species

• Validation Through Genetic Manipulation:

  • Compare signal intensities between wild-type and overexpression strains

  • Examine signal reduction in knockdown experiments

  • Use temperature-sensitive mutants to confirm specificity

• Signal Characterization Matrix:

  • Create a decision matrix for result interpretation:

  Observation	Control Result	Interpretation	Action Required
  Signal at expected MW	Absent in knockout	True positive	Proceed with analysis
  Signal at expected MW	Present in knockout	Potential artifact	Antibody validation needed
  Multiple bands	Some absent in knockout	Isoforms or modifications	Further characterization
  Multiple bands	All present in knockout	Non-specific binding	Optimization needed
  No signal	Positive control works	Low/no expression	Sensitivity optimization

• Biological Plausibility Assessment:

  • Evaluate consistency with known biology

  • Compare with published data on related proteins

  • Consider whether findings align with predicted protein function